New Methodology and Instrumentation for Follicular Unit Extraction: Lower Follicle Transection Rates and Expanded Patient Candidacy

    June 2008 in “ Dermatologic Surgery ”
    James A. Harris
    Image of study
    TLDR The SAFE System may improve hair transplant results but isn't suitable for everyone.
    The study introduced the SAFE System for Follicular Unit Extraction (FUE), which was tested on 59 patients and 6,947 grafts, resulting in an average follicle transection rate of 6.14%. The SAFE System was shown to potentially improve FUE techniques with a low adverse reaction rate. However, commentary by Walter Unger criticized the universal suitability of the SAFE System for all patients, noting that not all are ideal candidates as evidenced by a transection rate as high as 15% in at least one case. Unger also disputed the characterization of FUE as "minimally invasive" and questioned the claimed benefits of the procedure. Despite these concerns, Unger recognized the advantages of FUE in certain scenarios and suggested that the SAFE System could benefit novice surgeons by reducing transection rates.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 171 results

      community Verteporfin and Microneedling

      in Treatments 6 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

      community How is verteporfin doing in trials?

      in Chat  9 upvotes 1 year ago
      The conversation is about the progress of verteporfin in hair loss trials, with users expressing curiosity about its effectiveness and updates. Specific treatments mentioned include FUE (Follicular Unit Extraction) combined with verteporfin, with one reported case of donor area regrowth after a year, and three patients being monitored post-treatment by Dr. Bloxham with monthly updates on YouTube.

    Similar Research

    5 / 1000+ results
      Follicular Unit Extraction Hair Transplant

      research Follicular Unit Extraction Hair Transplant

      29 citations, January 2010 in “PubMed”
      FUE hair transplants offer minimal scarring and are good for short hairstyles but are time-consuming and can be costly.
      Commentary

      research Commentary

      1 citations, January 2006 in “Dermatologic Surgery”
      The SAFE System may reduce hair transplant transection rates but has been critiqued for not being as minimally invasive as claimed.
      Hair Transplantation for Men

      research Hair Transplantation for Men

      8 citations, January 2008 in “Journal of Cosmetic and Laser Therapy”
      Hair transplantation for men has improved, offering natural, lasting results, and may be enhanced by certain medications and future technologies.